Assessing risk for coronary heart disease: Beyond Framingham

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 572-580

  Cobb, Frederick R ^a,b   Kraus, William E ^a   Root, Martin ^a   Allen, Jason D ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; EDITORIAL; FAMILIAL DISEASE; GENDER; HEART DEATH; HUMAN; IMMOBILIZATION; ISCHEMIC HEART DISEASE; MEDICAL ASSESSMENT; MEDICAL SOCIETY; METABOLIC DISORDER; MICROALBUMINURIA; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0142088825     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00500-3     Document Type: Editorial

References (67)

1. Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:356-62.
2. Grundy SM, Balady GJ, Criqui MH, et al. Guide to primary prevention of cardiovascular diseases: a statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation 1997;95:2329-31.
3. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel III). JAMA 2001;285:2486-97.
4. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.
5. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
6. Smith SC Jr, Greenland P, Grundy SM. AHA conference proceedings: prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation 2000;101:111-6.
7. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986;256:2823-8.
8. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
9. Grundy SM, Pasternak R, Greenland P, et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 1999;100:1481-92.
10. Cohn JN, Hoke L, Whitwam W, et al. Screening for early detection of cardiovascular disease in asymptomatic individuals. Am Heart J 2003;146:679-85.
11. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;96:3248-50.
12. Fletcher GF, Baady G, Glair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs from all Americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996;94:857-62.
13. Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the etiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999;318:1460-7.
14. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
15. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135.
16. Harjai KJ. Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen. Ann Intern Med 1999;131:376-86.
17. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
18. Dahlen GH. Lp(a) Lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-26.
19. Bostom AG, Cupples A, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: a prospective study. JAMA 1996;276:544-8.
20. Montalescot G, Collet JP, Choussat R, et al. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J 1998;19(Suppl H):H-11-7.
21. Pearson T, Mensah G, Alexander R, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-9.
23. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol 1995;76:24-33C.
24. Greenland P, Abrams J, Aurigemma GP, et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:e16-22.
25. Lusher TF, Boulanger CM, Yang Z, et al. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87:V36-44.
26. Thorne S, Mullen MJ, Clarkson P, et al. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 1998;32:110-6.
27. Verbeuren TJ, Jordaens FH, Zonnekeyn LL. Effect of hypercholesterolemia on vascular reactivity in the rabbit: endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circulation Research 1986;58:552-64.
28. Creager MA, Selwyn A. When 'normal' cholesterol levels injure the endothelium. Circulation 1997;96:3255-7.
29. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969;56:676-9.
30. Ouriel K, McDonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982;91:686-93.
31. Stanford W, Thompson BH, Weiss RM. Coronary artery calcification: clinical significance and current methods of detection. AJR Am J Roentgenol 1993;161:1139-46.
32. Guerci AD, Spadaro LA, Goodman KJ, et al. Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease. J Am Coll Cardiol 1998;32:673-9.
33. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
34. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-3.
35. Detrano R, Hsiai T, Wang S, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 1996;27:285-90.
36. Arad Y, Spadaro LA, Goodman K, et al. 3.6 years follow-up of 1136 asymptomatic adults undergoing electron beam CT (EBCT) of the coronary arteries [abstract]. J Am Coll Cardiol 1998;31(Suppl A):210A.
37. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999;99:2633-8.
38. Grundy SM. Coronary plaque as a replacement for age as a risk factor in global risk assessment. Am J Cardiol 2001;88:8-11E.
39. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9.
40. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
41. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
42. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
43. Zeiher AM, Drexler H, Wollschlager H, et al. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
44. Schroeder S, Enderle MD, Ossen R, et al. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J 1999;138:731-9.
45. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
46. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
47. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995;91:1981-7.
48. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
49. Tawakol A, Omland T, Gerhard M, et al. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-21.
50. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87:V67-76.
51. Allen JD, Wilson JB, Tulley RT, et al. Influence of age and normal plasma fibrinogen levels on flow mediated dilation in healthy adults. Am J Cardiol 2000;86:703-5.
52. Clarkson P, Celermajer DS, Powe AJ, et al. Endothelium-dependent dilation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997;96:3378-83.
53. Mullen MJ, Clarkson P, Donald AE, et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patient: a randomized, double-blind study. J Am Coll Cardiol 1998;31:1330-5.
54. Gokce N, Keaney JF Jr, Frei B, et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999;99:3234-40.
55. Clarkson P. Exercise training increases endothelial function in young men. J Am Coll Cardiol 1999;33:1379-85.
56. Anderson TJ, Elstein E, Haber H, et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 2000;35:60-6.
57. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10.
58. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002;105:1567-72.
59. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003;23:554-66.
60. Cohn JN, Finkelstein S, McVeigh G. Non-invasive pulse wave analysis for detection of arterial disease. Hypertension 1995;26:503-8.
61. Gerstein HC, Mann JFE, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
62. Hillege H, Fidler V, Diercks G, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
63. Smith SC Jr, Amsterdam E, Balady GJ, et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II. Circulation 2000;101:e12-6.
64. Exercise electrocardiogram and coronary heart disease mortality in the multiple risk factor intervention trial: multiple risk factor intervention research group. Am J Cardiol 1985;56:16-24.
65. Gordon DL, Ekelund LG, Karon JM, et al. Predictive value of the exercise tolerance test for mortality in North American men: the lipid research clinics mortality follow-up study. Circulation 1986;74:252-61.
66. Hu G, Root M. System and method for predicting disease onset. patent #6,110,109; USA; 2000. http://www.biosignia.com/ publications.html.
67. Hu G, Root M. Developing disease-specific and morbidity-based health risk assessment. In: Proceedings of the 36th Annual Meeting of the Society of Prospective Medicine; Pittsburgh, Pa: 2000 Available at: http://www.biosignia. com/publications. html.